Structured content for pharma

It takes pharma companies about five times longer to create content, compared to other industries. Delayed drug approvals turn into an average loss of $1 million dollars per day for pharma companies. Val Swisher and Regina Lynn Preciado from Content Rules recently published an interesting e-book: “Structured Content for Pharma – Making the Case for XML.” This e-book gives a lot of context on the importance of structured content in the pharma industry, which contributes to both a faster time to market and better safety compliance.